Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families

INTRODUCTION: The impact of crisaborole ointment, a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild to moderate atopic dermatitis (AD), on quality of life (QoL) was assessed in two identically designed phase 3 studies (AD-301: NCT02118766; AD-302: NCT02118792, both at http://www...

Descripción completa

Detalles Bibliográficos
Autores principales: Simpson, Eric L., Paller, Amy S., Boguniewicz, Mark, Eichenfield, Lawrence F., Feldman, Steven R., Silverberg, Jonathan I., Chamlin, Sarah L., Zane, Lee T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261115/
https://www.ncbi.nlm.nih.gov/pubmed/30345457
http://dx.doi.org/10.1007/s13555-018-0263-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261115/
https://www.ncbi.nlm.nih.gov/pubmed/30345457
http://dx.doi.org/10.1007/s13555-018-0263-0

Ejemplares similares